NPPA fixed retail price of 71 formulations: July 2025

Last Updated on July 28, 2025 by The Health Master

NPPA

Download NPPA notification No. S.O. 3001(E) dt 04-07-2025, the link is given below: The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 71 formulations under the Drugs (Prices Control) Order, 2013, vide S.O. 3001 (E) dt 04-07-2025 based on the decision of 134th Authority meeting dated 26-06-2025.

The notification states as follows:

In exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S. O. 5249(E) dated 11th November, 2022 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA), hereby fixes, the price as specified in column (6) of the table herein below as the retail price, exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof;

A table is given below the article

Note:

(a) The manufacturer of the above-mentioned formulations, i.e., the “new drug” under paragraph 2(1)(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.

(b) The manufacturer may add Goods and Services Tax only if they have actually paid it or it is payable to the Government on the retail price mentioned in column (6) of the above-mentioned table.

(c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013.

The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.

(d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.

(e) The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above, i.e., those who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to the fulfillment of all the applicable statutory requirements as laid down by the government under relevant statutes or rules, including manufacturing license permission from the competent authority, i.e., the central or state licensing authority, as may be applicable, by the concerned manufacturer/marketing company.

(f) In case the retail price of any of the aforesaid formulations is not complied with, as per the instant price notification and notes specified hereinabove, then the concerned manufacturer / marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.

(g) Consequent to the fixation of retail price of such formulation as specified in column (2) of the above table with the strength and name of the manufacturer and marketing company specified in the corresponding entries in Column (3) & (5) thereof, the price order(s) fixing the retail price of the formulation with specified strength for that Manufacturer and marketing company Companies as specified in corresponding entries in Columns (2), (3), and (5) thereof, if any, issued prior to this notification, stand superseded.

Table

Sl. No.	Medicines	Strength	Unit	Manufacturer & Marketing Company	Retail Price (Rs.)
(1)	(2)	(3)	(4)	(5)	(6)
1	Amoxycillin & Potassium clavulanate Tablets	Each Film coated tablet contains: Amoxycillin Trihydrate IP eq. to Amoxycillin 875 mg Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 125 mg	1 Tablet	M/s Medicef Pharma /M/s Cadila Pharmaceuticals Ltd.	41.04
2	Aspirin Gastro-resistant & Atorvastatin Capsules	Each hard gelatin capsule contains: Aspirin IP 75mg (As Gastro-resistant Pellets) Atorvastatin Calcium IP Eqv. to Atorvastatin 10mg (As Pellets)	1 Capsule	M/s Synokem Pharmaceuticals Ltd. / M/s Alkem Laboratories Ltd.	3.65
3	Budesonide, Glycopyrronium & Formoterol fumarate dihydrate inhalation	Each actuation delivers : Budesonide IP 200 mcg Glycopyrronium Bromide ph. Eur.eq. to Glycopyrronium 12.5 mcg Formoterol fumarate Dihydrate IP 6 mcg	1 Metered Dose	M/s Lupin Ltd.	6.11
4	Cefixime Oral Suspension	Each 5 ml of reconstituted suspension contains: Cefixime IP Equivalent to Cefixime Anhydrous 200 mg	1 ml	M/s Alps Communication Pvt. Ltd./ M/s Galpha Laboratories Ltd.	3.72
5	Ceftriaxone, Disodium Edetate & Sulbactum powder for solution for Infusion	Each vial contains: Ceftriaxone Sodium IP eq. to Ceftriaxone 1000 mg Disodium Edetate IP 37 mg Sulbactam Sodium IP eq. Sulbactam 500 mg	1 vial	M/s Protech Telelinks/ M/s Tyykem Pvt. Ltd.	515.57
6	Ceftriaxone, Disodium Edetate & Sulbactum powder for solution for Infusion	Each vial contains: Ceftriaxone Sodium IP eq. to Ceftriaxone 2000 mg Disodium Edetate IP 74 mg Sulbactam Sodium IP eq. Sulbactam 1000 mg	1 vial	M/s Protech Telelinks/ M/s Tyykem Pvt. Ltd.	1036.60
7	Combipack of Ceftriaxone, Disodium Edetate and Sulbactam powder for solution for Infusion	Each Combi-pack contains: (A) Ceftriaxone, Disodium Edetate and Sulbactam powder for solution for infusion 1.5gm Each Vial Contains: Ceftriaxone sodium IP eq. to Ceftriaxone 1000mg Disodium Edetate IP 37mg Sulbactam Sodium IP Equivalent to Sulbactam 500mg B) Sterile water for injections IP 10ml Each ampoules contains : Water for injection IP 10ml	1 vial	M/s BDR Pharmaceuticals International Pvt. Ltd. M/s Bluecross Laboratories Pvt. Ltd.	447.00
8	Combipack of Ceftriaxone, Disodium Edetate and Sulbactam powder for solution for Infusion	Each Combi-pack contains: (A) Ceftriaxone, Disodium Edetate and Sulbactam powder for solution for infusion 3.0 gm Each Vial Contains: Ceftriaxone sodium IP eq. to Ceftriaxone 2000 mg Disodium Edetate IP 74 mg Sulbactam Sodium IP Equivalent to Sulbactam 1000 mg B) Sterile water for injections IP 20 ml Each ampoules contains : Water for injection IP 20 ml	1 vial	M/s BDR Pharmaceuticals International Pvt. Ltd. M/s Bluecross Laboratories Pvt. Ltd.	626.00
9	Cefuroxime Axetil & Potassium Clavulanate Tablets	Each Film coated tablet contains: Cefuroxime Axetil IP Eq. to Cefuroxime 500 mg Potassium clavulanate Diluted IP Eq. to Clavulanic Acid 125 mg	1 Tablet	M/s Hetero Labs ltd./ M/s Troikaa Pharmaceuticals Ltd.	61.84
10	Ciprofloxacin & Dexamethasone Eye /Ear Drops	Ciprofloxacin Hydrochloride IP eq. to Ciprofloxacin 0.3% w/v Dexamethasone IP 0.1% w/v Bezalkonium Chloride Solution IP 0.02 % w/v (Preservative)	1 ml	M/s Hanuchem Laboratories/ M/s Aristo Laboratories Pvt. Ltd.	2.47

11	Combikit of Clarithromycin Tablets, Esomeprazole Tablets and Amoxicillin Tablets	Composition: Each Strip Contains: Clarithromycin Tablets IP 2 Tablets Each Film Coated Tablet Contains: Clarithromycin IP 500 mg Esomeprazole Tablets IP 2 Tablets Each enteric coated Tablet Contains: Esomeprazole Magnesium Trihydrate IP Equivalent to Esomeprazole 40 mg Amoxicillin Tablets USP 2 Tablets Each Film Coated Tablet Contains: Amoxycillin Trihydrate IP Equivalent to Amoxycillin 1000 mg	1 Tablet	M/s Malik Lifesciences Pvt. Ltd. / M/s Torrent Pharmaceuticals Ltd.	162.52
12	Empagliflozin & Metformin Hydrochloride Tablets	Each film coated tablet Contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 500 mg	1 Tablet	M/s Mediforce Healthcare Pvt. Ltd./ M/s Mankind Prime Labs Pvt. Ltd.	18.10
13	Empagliflozin & Metformin Hydrochloride (ER) Tablets	Each Film Coated Bilayered Tablet Contains: Empagliflozin 12.5mg Metformin Hydrochloride IP 1000mg (As Extended release)	1 Tablet	M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Blue Cross Laboratories Pvt. Ltd.	10.80
14	Empagliflozin & Metformin Hydrochloride Tablets	Each film coated tablet Contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 1000 mg	1 Tablet	M/s Mediforce Healthcare Pvt. Ltd./ M/s Mankind Prime Labs Pvt. Ltd.	19.64
15	Empagliflozin, Linagliptin & Metformin (ER) Tablets	Each film coated tablet contains: Empagliflozin 10 mg, Linagliptin 5 mg, Metformin Hydrochloride IP 1000 mg (As Extended release)	1 Tablet	M/s Pure & Cure Healthcare Pvt. Ltd. / M/s Aristo Pharmaceuticals Pvt. Ltd.	16.97
16	Empagliflozin, Linagliptin & Metformin (ER) Tablets	Each film coated tablet contains: Empagliflozin 25 mg, Linagliptin 5 mg, Metformin Hydrochloride IP 1000 mg (As Extended release)	1 Tablet	M/s Pure & Cure Healthcare Pvt. Ltd. / M/s Aristo Pharmaceuticals Pvt. Ltd.	20.54
17	Sitagliptin, Glimepiride & Metformin Hydrochloride tablets	Each Film Coated Tablet Contains: Glimepiride IP 1 mg Sitagliptin Phosphate Monohydrate IP Equivalent to Sitagliptin 50 mg Metformin Hydrochloride IP 500 mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s Torrent Pharmaceuticals Ltd.	12.98
18	Sitagliptin, Glimepiride & Metformin Hydrochloride tablets	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50 mg Glimepiride IP 1 mg Metformin Hydrochloride IP 500 mg	1 Tablet	M/s Exemed Pharmaceuticals/ M/s Micro Labs Ltd.	12.00
19	Sitagliptin, Glimepiride & Metformin Hydrochloride tablets	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50 mg Glimepiride IP 1 mg Metformin Hydrochloride IP 500 mg	1 Tablet	M/s Exemed Pharmaceuticals/ M/s Intas Pharmaceuticals Ltd.	12.98
20	Sitagliptin, Glimepiride &Metformin Hydrochloride Tablets	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg, Glimepiride IP 1 mg, Metformin Hydrochloride IP 500mg	1 Tablet	M/s Exemed Pharmaceuticals/ M/s Eris Lifesciences Ltd.	12.98

21	Sitagliptin, Glimepiride &Metformin Hydrochloride Tablets	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg, Glimepiride IP 1 mg, Metformin Hydrochloride IP 500mg	1 Tablet	M/s Exemed Pharmaceuticals/ M/s Lupin Ltd.	12.98
22	Sitagliptin, Glimepiride and Metformin Hydrochloride Tablets	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50 mg Glimepiride IP 1 mg Metformin Hydrochloride IP 500 mg	1 Tablet	M/s Exemed Pharmaceuticals/ M/s Mankind Pharma Ltd.	12.98
23	Sitagliptin, Glimepiride & Metformin Hydrochloride tablets	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50 mg Glimepiride IP 2 mg Metformin Hydrochloride IP 500 mg	1 Tablet	M/s Exemed Pharmaceuticals/ M/s Torrent Pharmaceuticals Ltd.	14.66
24	Sitagliptin, Glimepiride & Metformin Hydrochloride tablets	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50 mg Glimepiride IP 2 mg Metformin Hydrochloride IP 500 mg	1 Tablet	M/s Exemed Pharmaceuticals/ M/s Micro Labs Ltd.	14.00
25	Sitagliptin, Glimepiride & Metformin Hydrochloride tablets	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50 mg Glimepiride IP 2 mg Metformin Hydrochloride IP 500 mg	1 Tablet	M/s Exemed Pharmaceuticals/ M/s Intas Pharmaceuticals Ltd.	14.66
26	Sitagliptin, Glimepiride &Metformin Hydrochloride Tablets	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg, Glimepiride IP 2 mg, Metformin Hydrochloride IP 500mg	1 Tablet	M/s Exemed Pharmaceuticals/ M/s Lupin Ltd.	14.66
27	Sitagliptin,Glimepiride &Metformin Hydrochloride Tablets	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50 mg Glimepiride IP 2 mg Metformin Hydrochloride IP 500 mg	1 Tablet	M/s Exemed Pharmaceuticals/ M/s Mankind Pharma Ltd.	14.66
28	Itraconazole Capsules (Supra- Bioavailable formulation)	Each hard gelatin capsule contains: Itraconazole IP 65 mg	1 Capsule	M/s Ravenbhel Healthcare Pvt. Ltd/ M/s Intas Pharmaceuticals Ltd.	11.45
29	Levofloxacin Infusion	Each 100 ml contains: Levofloxacin Hemihydrate IP eq. to Levofloxacin 500 mg Dextrose (Anhydrous) IP 5% w/v	1 ml	M/s Axa Parenterals Ltd./ M/s Aristo Laboratories Pvt. Ltd.	1.46
30	Linezolid injection	Each 100ml contains: Linezolid IP 200 mg, Dextrose Anhydrous IP 5% w/v	1 ml	M/s Amanta Healthcare Ltd. / M/s Corona Remedies Pvt. Ltd.	1.60

31	Methylprednisolone Tablets	Each uncoated tablet contains: Methylprednisolone IP 8 mg	1 Tablet	M/s Innova Captab Ltd. / M/s Troikaa Pharmaceuticals Ltd.	5.22
32	Moxifloxacin Eye Drops	Moxifloxacin Hydrochloride IP Eq. to Moxifloxacin 0.5% w/v Benzalkonium Chloride Solution IP 0.02% v/v (as preservative) Sterile aqueous buffered vehicle	1 ml	M/s Hanuchem Laboratories / M/s Aristo Laboratories Pvt. Ltd.	36.26
33	Myo-Inositol,D-Chiro Inositol &Vitamin D3 Powder	Each 5g Sachet contains: Vitamin D3 (Stabilized form) 1000 IU, Myo-Inositol IP 2000 mg, D-Chiro Inositol 50 mg	1 gm	M/s Safetab Life Science/ M/s Corona Remedies Pvt. Ltd.	9.02
34	Paracetamol bilayered sustained release tablets	Each uncoated bilayered sustained release tablet contains: Paracetamol IP (as Immediate release ) 300 mg Paracetamol IP (as sustained release) 700 mg	1 Tablet	M/s Pure and cure Healthcare Pvt. Ltd./ M/s Glaxosmithkline Asia Pvt. Ltd.	4.71
35	Paracetamol Oral Suspension	Each 5 ml Contains: Paracetamol IP 500 mg	1 ml	M/s Naxpar Pharma Pvt. Ltd./ M/s Micro Labs Ltd.	0.66
36	Paracetamol Oral Suspension	Each 5ml contains: Paracetamol IP 500mg	1 ml	M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Alkem Laboratories Ltd.	0.66
37	Ibuprofen & Paracetamol suspension	Each 5 ml contains: Ibuprofen IP 100 mg Paracetamol IP 162.5 mg	1 ml	M/s Mascot Health Series Pvt. Ltd./ M/s Alembic Pharmaceuticals Ltd.	0.53
38	Mefenamic Acid & Paracetamol suspension	Each 5 ml contains: Mefenamic Acid IP 100 mg Paracetamol IP 250 mg	1 ml	M/s Mascot Health Series Pvt. Ltd./ M/s Alembic Pharmaceuticals Ltd.	0.94
39	Paracetamol, Phenylephrine Hydrochloride & Chlorpheniramine Maleate Tablets	Each uncoated tablet contains: Paracetamol IP 500 mg Phenylephrine Hydrochloride IP 10 mg Chlorpheniramine Maleate IP 2 mg	1 Tablet	M/s East African (India) Overseas / M/s Aristo Laboratories Pvt. Ltd.	5.25
40	Polmacoxib & Paracetamol Tablets	Each uncoated tablet contains: Polmacoxib IH 2 mg, Paracetamol IP 325 mg	1 Tablet	M/s Hetero Labs Ltd. / M/s Intas Pharmaceuticals Ltd.	15.39

41	Aceclofenac, Paracetamol & Trypsin Chymotrypsin Tablets	Each enteric coated tablet contains: Proteolytic enzymes Trypsin & Chymotrypsin in the ratio of Approximately 6:1 and provides enzymatic activity Eq. to 1,50,000 Armour units Aceclofenac IP 100 mg Paracetamol IP 325 mg	1 Tablet	M/s Akums Drugs & pharmaceuticals Ltd / M/s Aristo Pharmaceutical Pvt. Ltd	15.18
42	Trastuzumab for Injection	Each Lyophilized vial contains: Trastuzumab (In House) (375 mg) – α, α Trehalose dihydrate Ph. Eur. (340.91 mg) – L-Histidine HCl monohydrate Ph. Eur. (8.44 mg) -L-Histidine Ph. Eur. (5.45 mg) – Polysorbate 20 IP (1.53 mg)	1 vial	M/s Reliance Life Sciences Pvt. Ltd.	11966.64
43	Vitamin D3 (Cholecalciferol) Drops	Each ml contains: Cholecalciferol (Vitamin D3) IP 800 IU	1 ml	M/s Indchemie Health Specialities Pvt. Ltd.	6.11
44	Zolpidem Tartrate & Melatonin tablets	Each film coated tablet contains: Zolpidem Tartrate IP 5 mg Melatonin BP 3 mg	1 Tablet	M/s Windlas Biotech Ltd./ M/s Intas Pharmaceuticals Ltd.	6.62
45	Phenylephrine HCl, Chlorpheniramine Maleate, Boric Acid & Hydroxypropylmethyl Cellulose Eye Drops	Composition: Phenylephrine HCl IP 0.12 %w/v Chlorpheniramine Maleate IP 0.2 % w/v Boric Acid IP 1.25 % w/v Hydroxypropylmethyl Cellulose IP 0.3 % w/v Benzalkonium Choride IP 0.01 % w/v	1 ml	M/s Appasamy Ocular Devices Pvt. Ltd./ M/s Intas Pharmaceuticals Ltd.	7.63
46	Methylcobalamin , Alpha Lipoic Acid, Pyridoxine Hydrochloride & Folic Acid Capsules	Each hard gelatin capsule contains : Methylcobalamin IP 1500 mcg Alpha Lipoic Acid IP 100 mg Pyridoxine Hydrochloride IP 3 mg Folic Acid IP 1.5mg	1 Capsule	M/s East African (India) Overseas/ M/s Softdeal Pharmaceutical Pvt. Ltd.	14.64
47	Zolpidem Tartrate & Melatonin tablets	Each film coated tablet contains: Zolpidem Tartrate IP 10 mg Melatonin BP 3 mg	1 Tablet	M/s Windlas Biotech Ltd./ M/s Intas Pharmaceuticals Ltd.	9.02
48	Myo-Inositol, D-Chiro Inositol & Vitamin D3 powder	Each 5g Sachet contains: Vitamin D3 IP (Water soluble) 1000 IU Myo-Inositol IP 2000 mg D-Chiro Inositol 50 mg	1 gm	M/s Safetab Life Science / M/s Sun Pharma Laboratories Limited	9.02
49	Metoprolol succinate (ER), Amlodipine & Telmisartan Tablets	Each film coated bilayered tablet contains: Metoprolol Succinate IP 23.75 mg eq. to Metoprolol Tartrate 25 mg (As extended release) Amlodipine Besilate IP eq. to Amlodipine 5 mg Telmisartan IP 40 mg	1 Tablet	M/s Ajanta Pharma Ltd.	12.96
50	Dehydroepiandrosterone (DHEA)(Micronised) & Folic Acid Capsules	Each hard gelatin capsule contains: Dehydroepiandrosterone (DHEA)(Micronised) 25 mg, Folic Acid IP 1.5 mg	1 Capsule	M/s Akums Drugs & Pharmaceuticals Ltd./ M/s Sun Pharma Laboratories Ltd.	14.08

51	Glycopyrronium & Formoterol Fumarate inhaler	Each actuation delivers: Glycopyrronium (As Glycopyrrolate IP) 12.5mcg Formoterol Fumarate Dihydrate IP 6mcg	1 meterede dose	M/s Cipla Ltd.	4.08
52	Empagliflozin, Sitagliptin & Metformin Hydrochloride (ER) Tablets	Each film coated bilayer tablet contains: Empagliflozin 10 mg, Sitagliptin Phosphate Monohydrate IP equivalent to Sitagliptin 100 mg, Metformin Hydrochloride IP 1000 mg (as extended release)	1 Tablet	M/s Exemed Pharmaceuticals / M/s Corona Remedies Pvt. Ltd.	31.60
53	Empagliflozin, Sitagliptin & Metformin (ER) tablets	Each Film Coated Bilayer Tablet contains: Empagliflozin 10 mg Sitagliptin Phosphate Monohydrate IP Equivalent to Sitagliptin 100 mg Metformin Hydrochloride IP (As Extended Release) 1000 mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s Zydus Healthcare Limited	31.60
54	Empagliflozin, Sitagliptin & Metformin Hydrochloride (ER) Tablets	Each Film Coated bilayer Tablet Contains: Empagliflozin 10 mg Sitagliptin Phosphate Monohydrate IP Equivalent to Sitagliptin 100mg Metformin Hydrochloride IP (As Extended Release) 1000mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s Alkem Laboratories Ltd.	31.60
55	Empagliflozin ,Sitagliptin & Metformin Hydrochloride (ER) Tablets	Each film coated bilayer tablet contains: Empagliflozin 10mg Sitagliptin Phosphate Monohydrate IP equivalent to Sitagliptin 100mg Metformin Hydrochloride IP (As extended release) 1000mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s Lupin Ltd	25.00
56	Empagliflozin, Sitagliptin & Metformin Hydrochloride (ER) Tablets	Each Film Coated bilayer Tablet Contains: Empagliflozin 10 mg Sitagliptin Phosphate Monohydrate IP Equivalent to Sitagliptin 100mg Metformin Hydrochloride IP (As Extended Release) 1000mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s Torrent Pharmaceuticals Ltd.	22.50
57	Empagliflozin, Sitagliptin & Metformin Hydrochloride (ER) Tablets	Each Film Coated bilayer Tablet Contains: Empagliflozin 10 mg Sitagliptin Phosphate Monohydrate IP Equivalent to Sitagliptin 100mg Metformin Hydrochloride IP (As Extended Release) 1000mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s Mankind Pharma Ltd.	31.60
58	Empagliflozin, Sitagliptin & Metformin Hydrochloride (ER) Tablets	Each Film Coated bilayer Tablet Contains: Empagliflozin 10 mg Sitagliptin Phosphate Monohydrate IP Equivalent to Sitagliptin 100mg Metformin Hydrochloride IP (As Extended Release) 1000mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s Intas Pharmaceuticals Ltd.	25.00
59	Empagliflozin, Sitagliptin & Metformin Hydrochloride (ER) Tablets	Each film coated bilayer tablet contains: Empagliflozin 10 mg, Sitagliptin Phosphate Monohydrate IP equivalent to Sitagliptin 100 mg, Metformin Hydrochloride IP 1000 mg (as extended release)	1 Tablet	M/s Exemed Pharmaceuticals / M/s Eris Lifesciences Ltd.	31.60
60	Empagliflozin, Sitagliptin & Metformin Hydrochloride (ER) Tablets	Each film coated bilayer tablet contains: Empagliflozin 10 mg, Sitagliptin Phosphate Monohydrate IP equivalent to Sitagliptin 100 mg, Metformin Hydrochloride IP 1000 mg (as extended release)	1 Tablet	M/s Exemed Pharmaceuticals / M/s Cipla Ltd.	22.00

61	Empagliflozin, Sitagliptin & Metformin Hydrochloride (ER) Tablets	Each Film Coated bilayer Tablet Contains: Empagliflozin 10 mg Sitagliptin Phosphate Monohydrate IP Equivalent to Sitagliptin 100mg Metformin Hydrochloride IP (As Extended Release) 1000mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s Sun Pharmaceuticals Industries Ltd.	26.00
62	Empagliflozin, Sitagliptin & Metformin Hydrochloride (ER) Tablets	Each film coated bilayer tablet contains: Empagliflozin 25 mg, Sitagliptin Phosphate Monohydrate IP equivalent to Sitagliptin 100 mg, Metformin Hydrochloride IP 1000 mg (as extended release)	1 Tablet	M/s Exemed Pharmaceuticals / M/s Cipla Ltd.	23.00
63	Empagliflozin, Sitagliptin & Metformin Hydrochloride (ER) Tablets	Each film coated bilayer tablet contains: Empagliflozin 25 mg, Sitagliptin Phosphate Monohydrate IP equivalent to Sitagliptin 100 mg, Metformin Hydrochloride IP 1000 mg (as extended release)	1 Tablet	M/s Exemed Pharmaceuticals / M/s Eris Lifesciences Ltd.	35.19
64	Empagliflozin, Sitagliptin & Metformin Hydrochloride (ER) Tablets	Each Film Coated bilayer Tablet Contains: Empagliflozin 25mg Sitagliptin Phosphate Monohydrate IP Equivalent to Sitagliptin 100mg Metformin Hydrochloride IP (As Extended Release) 1000mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s Mankind Pharma Ltd.	35.19
65	Empagliflozin, Sitagliptin & Metformin Hydrochloride (ER) Tablets	Each Film Coated bilayer Tablet Contains: Empagliflozin 25 mg Sitagliptin Phosphate Monohydrate IP Equivalent to Sitagliptin 100mg Metformin Hydrochloride IP (As Extended Release) 1000mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s Torrent Pharmaceuticals Ltd.	25.00
66	Empagliflozin, Sitagliptin & Metformin Hydrochloride (ER) Tablets	Each Film Coated bilayer Tablet Contains: Empagliflozin 25 mg Sitagliptin Phosphate Monohydrate IP Equivalent to Sitagliptin 100mg Metformin Hydrochloride IP (As Extended Release) 1000mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s Sun Pharmaceuticals Industries Ltd.	30.00
67	Empagliflozin, Sitagliptin & Metformin Hydrochloride (ER) Tablets	Each Film Coated bilayer Tablet Contains: Empagliflozin 25 mg Sitagliptin Phosphate Monohydrate IP Equivalent to Sitagliptin 100mg Metformin Hydrochloride IP (As Extended Release) 1000mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s Intas Pharmaceuticals Ltd.	26.00
68	Empagliflozin, Sitagliptin & Metformin Hydrochloride (ER) Tablets	Each Film Coated bilayer Tablet Contains: Empagliflozin 25mg Sitagliptin Phosphate Monohydrate IP Equivalent to Sitagliptin 100mg Metformin Hydrochloride IP (As Extended Release) 1000mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s Alkem Laboratories Ltd.	34.00
69	Empagliflozin ,Sitagliptin & Metformin Hydrochloride (ER) Tablets	Each film coated bilayer tablet contains: Empagliflozin 25 mg Sitagliptin Phosphate Monohydrate IP equivalent to Sitagliptin 100mg Metformin Hydrochloride IP (As extended release) 1000mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s Lupin Ltd	30.00
70	Empagliflozin, Sitagliptin & Metformin (ER) tablets	Each Film Coated Bilayer Tablet contains: Empagliflozin 25 mg Sitagliptin Phosphate Monohydrate IP Equivalent to Sitagliptin 100 mg Metformin Hydrochloride IP (As Extended Release) 1000 mg.	1 Tablet	M/s Exemed Pharmaceuticals / M/s Zydus Healthcare Limited	35.19
71	Empagliflozin, Sitagliptin & Metformin Hydrochloride (ER) Tablets	Each film coated bilayer tablet contains: Empagliflozin 25mg, Sitagliptin Phosphate Monohydrate IP equivalent to Sitagliptin 100mg, Metformin Hydrochloride IP 1000mg (as extended release)	1 Tablet	M/s Exemed Pharmaceuticals / M/s Corona Remedies Pvt. Ltd.	35.19

• IP 2026 released: Salient Features
  January 7, 2026
• Drug alert: 205 drug samples declared as NSQ in November 2025
  December 25, 2025
• FDA Haryana is Redefining Drug Safety and MSMEs Growth
  December 17, 2025
• 10th edition of IP for standards of drugs in India
  December 9, 2025
• QR Code mandatory at every Medical Store for ADR reporting
  November 26, 2025
• Landmark Seminar by FDA Haryana on Spurious drugs and NDPS Misuse
  November 25, 2025